Events for “gilead”

FDA approves daily HIV pill from Gilead designed to simplify treatment for some patients

The new pill is also aimed at people who are doing well on a single-tablet regimen, including Biktarvy, and want to switch to a new treatment.

Gilead’s HIV Business is Surging, but is the Company Too Dependent on One Franchise?

Gilead’s Revenue Is Accelerating, But are its Acquisitions Worth the Cost?

Pfizer vs. Gilead: Which Drugmaker Has the Stronger Growth Story?